RNAi therapeutics, has quickly been established as a robust and effective gene silencing strategy and has several distinct advantages over traditional pharmaceutical drugs. The reason of the limited number of siRNA delivery systems in clinical trials is certainly the complexity of the approach. It is easier to administer naked or modified siRNA than to develop an efficient, reproducible and safe delivery system which has to undergo the same regulatory guidelines as the drug itself. The nature and extent of these gene expression changes are dependent on several factors including delivery system variables such as its chemistry, lipid architecture, charge, dose, the degree of saturation of cationic lipids affects lipid pKa, fusogenicity, cellular uptake, gene silencing ability and biological variables. Extensive investigations into the chemistry and physics of cationic lipids and their transfection efficiencies points in lipoplex formulation are equally important for transfection.


German Innovation Award

Dr. Ranjita Shegokar, CSO was honored with a German Innovation Award 2022 jointly with Prof. Marc A. Reymond, MD MBA (AACSB), CEO, CapnoPharm GmbH, for their collaborative, innovative research work in the field of cancer. https://www.german-innovation-award.de/en/winners/preis/gewinner/capnopen-capnodrugs/

ACES Award

German medical device firm races to provide alternative treatments to treat cancer

Revolutionizing Cancer Treatment


Hon’ble Ministers of State Shri Ashok Chandra Panda, Science & Technology, Public Enterprises, Social Security & Empowerment of Persons with Disability inaugurated the event in the auspicious presence of Padma Vibhusan Pandit Hariprasad Chaurasia and Padmashri Pt. Bhajan Sapori   15 women achievers in distinct categories felicitated with the prestigious award   Parichay Foundation presents… Continue reading AARYA Award

International Inspirational Women Awards 2020


16 Best New Drug Delivery Systems Books To Read In 2021 – BookAuthority